Smith Hayes Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2.7M Sell
28,094
-188
-0.7% -$17.1K 0.55% 49
2015
Q4
$2.56M Sell
28,282
-683
-2% -$64.3K 0.54% 50
2015
Q3
$2.68M Buy
28,965
+42
+0.1% +$3.99K 0.58% 49
2015
Q2
$2.69M Sell
28,923
-1,260
-4% -$118K 0.53% 59
2015
Q1
$2.86M Buy
30,183
+356
+1% +$33K 0.57% 51
2014
Q4
$2.64M Buy
29,827
+5
+0% +$424 0.55% 52
2014
Q3
$2.38M Buy
29,822
+1,505
+5% +$113K 0.56% 55
2014
Q2
$2.01M Buy
28,317
+2,871
+11% +$202K 0.47% 66
2014
Q1
$1.88M Buy
25,446
+36
+0.1% +$2.72K 0.47% 67
2013
Q4
$1.99M Sell
25,410
-682
-3% -$53.4K 0.66% 45
2013
Q3
$1.93M Buy
26,092
+605
+2% +$44.6K 0.74% 41
2013
Q2
$1.94M Buy
+25,487
New +$1.67M 0.8% 40

Other funds holding CME

Smith Hayes Advisers's CME Position: Q1 2016 in Review

Smith Hayes Advisers reduced its CME Group (CME) stake by 0.66% in Q1 2016, selling an estimated $17.1K and leaving 28,094 shares worth $2.7M. The position accounts for 0.55% of the portfolio, ranked #49.

Smith Hayes Advisers first reported a position in CME in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.86M in Q1 2015. 632 funds tracked by Wall St. Rank hold CME as of Q1 2016.

  • Smith Hayes Advisers held 28,094 shares of CME Group worth $2.7M as of Q1 2016.
  • Smith Hayes Advisers sold 188 CME Group shares in Q1 2016, an estimated $17.1K.
  • CME Group made up 0.55% of Smith Hayes Advisers's portfolio in Q1 2016, its #49 holding.
  • Smith Hayes Advisers first reported a position in CME Group in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's CME Group position peaked at $2.86M in Q1 2015.
  • 632 funds tracked by Wall St. Rank held CME Group as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.